<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e> is the most common genetic form of <z:hpo ids='HP_0003510'>dwarfism</z:hpo> inherited as an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorder </plain></SENT>
<SENT sid="1" pm="."><plain>Individuals affected with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> have impaired ability to form bone from cartilage (endochondral bone formation) </plain></SENT>
<SENT sid="2" pm="."><plain>Homozygous <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> is a <z:hpo ids='HP_0003811'>neonatal lethal</z:hpo> condition </plain></SENT>
<SENT sid="3" pm="."><plain>The vast majority of patients with <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> have a G-to-A transition at position 1138 of the fibroblast growth factor receptor 3 (FGFR3) cDNA sequence, resulting in the Gly-to-Arg substitution at position 380 of the FGFR3 protein </plain></SENT>
<SENT sid="4" pm="."><plain>This mutation has been diagnosed by SfcI digestion of amplified genomic DNA </plain></SENT>
<SENT sid="5" pm="."><plain>However, it has also been demonstrated that the SfcI digestion protocol does not consistently distinguish between DNA samples heterozygous and homozygous for the G1138A substitution </plain></SENT>
<SENT sid="6" pm="."><plain>This study was designed to improve the molecular diagnosis based on the polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques for the FGFR3 G1138A mutation </plain></SENT>
<SENT sid="7" pm="."><plain>The newly designed forward primer contains one mismatch (G at position 1136) from the FGFR3 cDNA sequence (A at position 1136), thereby creating a PstI site (CTGCAG at positions 1134 to 1139) in the amplified DNA from alleles containing the G1138A mutation </plain></SENT>
<SENT sid="8" pm="."><plain>The PCR-RFLP technique based on the PstI digestion of amplified genomic DNA with a novel forward primer shows 100% accuracy in diagnosis of the G1138A mutation in heterozygous and homozygous individuals </plain></SENT>
</text></document>